Hepatitis B s100 Prescriber Course

Date
28 Apr 2019
08:30 AM - 05:00 PM
Cost
Free
Available to
General Practitioners
Continuing Professional Development

RACGP 40 x Cat 1 points

Register now
Event Location
North Western Melbourne PHN - Yarra Room
Level 5, 369 Royal Parade
PARKVILLE VIC 3052
Australia

Advanced level training that will enable GPs to effectively diagnose, manage and treat chronic hepatitis B in the primary care setting. Successful completion of the training and assessment will accredit community-based medical practitioners to prescribe s100 highly specialised drugs for the treatment of chronic hepatitis B.

This interactive coursewill involve online learning modules, in-depth presentations, case discussions, and facilitated group work giving attendees an opportunity to discuss practical strategies with peers and specialists.

It will be facilitated by:

Associate Professor Benjamin Cowie - an infectious diseases physician and epidemiologist, with appointments at The Doherty Institute, the Victorian Department of Health and Human Services, and  the University of Melbourne. Ben has been involved in the development of health public policy in relation to viral hepatitis in Australia and internationally, and in 2015 was named the inaugural Director of the WHO Collaborating Centre for Viral Hepatitis at The Doherty Institute.

Doctor Matt Penn - Registered s100 HIV and Hepatitis B prescriber who works at the Centre Clinic, PRONTO and North Richmond Community Health. Matt also has experience in prescribing HIV Pre Exposure Prophylaxis (PrEP) and further interested in Hepatitis C management and sexual health. 


Further Details:
Morning/afternoon tea and lunch will be provided.
Registrations are essential. RSVP by Friday 19th April 2019

Travel Grants:
Travel grants may be provided to GPs in rural and remote Victoria to attend the course and become a HBV s100 prescriber. For more information please contact: VHHITAL@nwmphn.org.au  

Please note this course is funded by the Victorian State Govt and interstate participants are welcome to attend subject to space. A $660 fee will apply for all interstate participants. 

Learning outcomes:

  • Screen at risk patients appropriately
  • Plan antiviral treatment for HBV infection
  • Utilise treatment protocols for monitoring patients’ responses to HBV antiviral therapy
  • Implement shared care between primary and tertiary settings including appropriate referrals
  • Develop management plans for patients requiring ongoing monitoring